
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare Corp has demonstrated strong organic revenue growth, specifically a remarkable increase of 12.3% year-over-year in 2023, which is expected to moderate to 7.7% in 2024 and 7.4% in 2025 YTD, indicating a resilient demand for its personal care services. The recent announcement of a 2.6% Medicare Hospice rate increase, effective October 2025, provides a favorable regulatory environment that is poised to enhance the profitability of its Hospice segment. Additionally, as this segment stabilizes, potential mergers and acquisitions, alongside operational improvements, are identified as key contributors to sustained revenue growth in the coming years.
Bears say
Addus HomeCare has experienced same-store declines in 2025 year-to-date due to ongoing Medicaid redeterminations, which have caused administrative bottlenecks in onboarding new patients and resulted in higher discharge rates compared to admissions. Approximately 97% of the company's segment revenues are affected by the uncertain Medicaid funding environment, especially in light of the One Big Beautiful Bill Act (OBBBA), which raises concerns about future revenue stability. Despite maintaining a favorable long-term demand backdrop and steady execution, the disconnect between Addus's equity valuation and its fundamental earnings trajectory indicates potential vulnerabilities in its financial outlook.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares